Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with mild-moderate fibrosis, with or without glucose abnormalities: interim results of the EGG18 study
Titel:
Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with mild-moderate fibrosis, with or without glucose abnormalities: interim results of the EGG18 study
Auteur:
Calvaruso, V. Petta, S. Ferraro, D. La Mantia, C. Reina, G. Zarcone, A. Assanto, E. Di Marco, V. Craxì, A.